Needlestick injury after a local anesthetic injection
A 29-year-old dental hygienist sustains a needlestick injury while recapping a local anesthetic needle after an inferior alveolar nerve block. The patient is a 41-year-old man with a history of hepatitis C treated 5 years ago with sustained virologic response, but his current status is unknown. The hygienist received a complete hepatitis B vaccination series 8 years ago; her anti-HBs titer is 15 mIU/mL and she has never been tested for anti-HBc. Her HIV status is negative. The injury drew blood. The needle had been in the patient's mouth and was contaminated with blood. The clinic has a written exposure control plan, but the hygienist has not attended annual infection-control training. She asks whether she needs any treatment and whether she should report the incident.
1. Describe the immediate wound care and reporting steps after this needlestick.
Read the worked answer
Immediate care is wash the wound with soap and water, allow it to bleed freely, and do not squeeze or scrub. Do not apply caustic agents. Then report immediately to the occupational health service or designated exposure officer and complete an incident report. Reporting is not optional and should not be punitive; it is required to access risk assessment, source testing, and post-exposure prophylaxis within the time window.
The source patient should be approached for consent to test for HIV, hepatitis B, and hepatitis C, with confidential counseling. If the source cannot be tested or refuses, the exposure should be managed on the assumption of risk. The hygienist's baseline serology and vaccination history should be documented, including anti-HBs and anti-HBc.
The root cause also needs review: recapping is a prohibited high-risk practice. A safer method is a one-handed scoop or a needle safety device. The clinic's written plan is not enough if staff have not been trained, so the incident should trigger retraining.
2. What is the hepatitis B and hepatitis C post-exposure management for this hygienist?
Read the worked answer
Her anti-HBs is 15 mIU/mL, which is above the protective threshold of 10 mIU/mL, so she is a documented vaccine responder. If the source is HBsAg-positive, a vaccinated responder does not need hepatitis B immune globulin or a booster; her protection is adequate. If her anti-HBs had been below 10 mIU/mL, she would need HBIG and a booster dose, and she should be tested for anti-HBc to determine whether she has had prior infection. Because her anti-HBs is 15, the main action is documentation and source testing, not immediate HBIG.
For hepatitis C, there is no post-exposure prophylaxis. Management is source testing for HCV RNA, baseline testing of the hygienist, and follow-up testing at an appropriate interval, with early referral for direct-acting antiviral treatment if seroconversion occurs. A history of sustained virologic response in the source does not guarantee that he is currently aviremic; current HCV RNA testing is needed.
This is why source testing and occupational health follow-up matter more than giving a drug.
3. Does she need HIV post-exposure prophylaxis, and how would you decide?
Read the worked answer
HIV post-exposure prophylaxis is decided by the source's HIV status and the exposure risk, not by the hygienist's negative status. This was a percutaneous needlestick with visible blood, so it is a higher-risk exposure. If the source is HIV-positive or his status is unknown and he has risk factors, PEP should be started as soon as possible, ideally within 2 hours and no later than 72 hours, after baseline HIV testing and counseling. A three-drug regimen is standard, and adherence and follow-up testing are essential.
If the source tests HIV-negative and has no recent risk exposure, PEP is not indicated. If the source refuses testing, the decision should be individualized with occupational health or infectious disease advice; the default in an unknown high-risk source is to offer PEP.
The hygienist should also be advised about safe sex practices during follow-up and about the need for repeat HIV testing. Documentation should record the risk assessment, the timing of presentation, and the decision, including any patient refusal.